Search Results - Chisato Ohe

Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report by Kensuke Suzuki, Hiroshi Harada, Masayuki Takeda, Chisato Ohe, Yoshiko Uemura, Akihiko Kawahara, Shunsuke Sawada, Akira Kanda, Bhaswati Sengupta, Hiroshi Iwai

Connect to this object online.

Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma by Junichi Ikeda, Chisato Ohe, Noritaka Tanaka, Takashi Yoshida, Ryoichi Saito, Naho Atsumi, Takashi Kobayashi, Hidefumi Kinoshita, Koji Tsuta, Takeharu Sakamoto

Connect to this object online.

Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma by Takashi Yoshida, Chisato Ohe, Junichi Ikeda, Naho Atsumi, Ryoichi Saito, Hisanori Taniguchi, Haruyuki Ohsugi, Motohiko Sugi, Koji Tsuta, Tadashi Matsuda, Hidefumi Kinoshita

Connect to this object online.

Useful diagnostic histogenetic features of ectopic odontogenic ghost cell tumours by Yuri Noda, Chisato Ohe, Mitsuaki Ishida, Kimiaki Okano, Kaori Sando, Naoya Hada, Yusuke Ebisu, Takuo Fujisawa, Masao Yagi, Hiroshi Iwai, Koji Tsuta

Connect to this object online.

Chromophobe renal cell carcinoma with neuroendocrine differentiation/morphology: A clinicopathological and genetic study of three cases by Chisato Ohe, MD, Naoto Kuroda, MD, Keiko Matsuura, MD, PhD, Tomoki Kai, MD, Masatsugu Moriyama, MD, PhD, Shun Sugiguchi, MD, Shintaro Terahata, MD, Naoki Hosaka, MD, PhD, Ondrej Hes, MD, PhD, Michal Michal, MD, Tadashi Matsuda, MD, Yoshiko Uemura, MD

Connect to this object online.